• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    Pharmacyclics Inc. (PCYC)

    -NasdaqGS
    255.95 Down 0.48(0.19%) 4:00PM EDT
    |After Hours : 255.94 Down 0.01 (0.00%) 4:38PM EDT
    Add to Portfolio
    Prev Close:256.43
    Open:256.45
    Bid:4.50 x 200
    Ask:257.00 x 100
    1y Target Est:243.34
    Beta:0.74
    Next Earnings Date:N/A
    Day's Range:255.50 - 256.83
    52wk Range:82.51 - 258.95
    Volume:824,704
    Avg Vol (3m):1,652,360
    Market Cap:19.46B
    P/E (ttm):232.68
    EPS (ttm):1.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PCYC

    Comparison

    Symbol% ChgMkt Cap
    PCYCDown 0.19%19.46B
    CTICDown 3.21%314.41M
    MRKDown 1.47%163.14B

    Key Statistics

    Forward P/E (1 yr):58.84
    P/S (ttm):26.71
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.50
    Quarterly EPS Est (Mar-15) :0.12
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):3,205.38

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pharmacyclics, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for the treatment of cancer and immune-mediated diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback